Who
Derek Miller
SVP, Human Resources
Company insider
Files Form 4 as: SVP, Human Resources, Amgen.
In numbers
- Trades disclosed
- 61
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $3.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Mar 2022
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $336K2,069 at $162.60 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $833K2,069 at $402.54 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $323K1,821 at $177.46 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,069 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,821 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $733K1,821 at $402.54 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,069 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,821 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $336K2,069 at $162.60 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $833K2,069 at $402.54 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $323K1,821 at $177.46 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $733K1,821 at $402.54 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $50K151 at $331.11 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $50K151 at $331.11 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $41K123 at $329.59 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $41K123 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —910 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $2.0M5,938 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $2.0M5,938 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —910 at $0.00 | filing |
News
Amgen Has the Drugs and the Dividend. Now It Needs the GrowthAMGN · insidermonkey.com · 19 Oct 2026Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?AMGN · insidermonkey.com · 13 Oct 2026Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer's Eye for Different ReasonsAMGN · insidermonkey.com · 8 Oct 2026
0 headlines in the last 90 days name Derek Miller; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.